Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models-Reference-Cited by-同舟云学术

Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models

Published:2019-06 Issue: Volume:372 Page:57-69
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Yan Hangyi,Bhagwat Bhagyashree,Sanden David,Willingham Aarron,Tan Alick,Knapton Alan D.,Weaver James L.,Howard Kristina E.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference31 articles.

1. AG T. Investigators brochure - TGN1412 Humanized agonistic anti-CD28 monoclonal antibody 2005 [Available from: http://www.circare.org/foia5/tgn1412investigatorbrochure.pdf.

2. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rgamma(null) humanized mice;Billerbeck;Blood.,2011

3. Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model;Brady;Clin. Transl. Immunol.,2014

4. Cytokine-release syndrome: overview and nursing implications;Breslin;Clin. J. Oncol. Nurs.,2007

5. Cytokine release assays: current practices and future directions;Finco;Cytokine.,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes;2024-04-02

2. Support for Removing Pharmacodynamic and Clinical Efficacy Testing of Biosimilars: A Critical Analysis;Clinical Pharmacology in Drug Development;2023-11-14

3. Progress, implications, and challenges in using humanized immune system mice in CAR‐T therapy—Application evaluation and improvement;Animal Models and Experimental Medicine;2023-10-12

4. Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures;Frontiers in Immunology;2023-05-25

5. Simultaneous evaluation of treatment efficacy and toxicity for bispecific T‐cell engager therapeutics in a humanized mouse model;The FASEB Journal;2023-05-23